Eli Lilly to acquire Seattle-area biotech in $1.5 billion bet on next-generation shingles vaccine

https://cdn.geekwire.com/wp-content/uploads/2022/11/George-Simeon.jpeg" width="300" />
Eli Lilly agreed to acquire Bothell, Wash.-based Curevo Vaccine for up to $1.5 billion in cash.

The deal centers on a next-generation shingles vaccine that reduced side effects by more than half in a Phase 2 study. https://www.geekwire.com/2026/eli-lilly-to-acquire-seattle-area-biotech-in-1-5-billion-bet-on-next-generation-shingles-vaccine/">Read More